Meglutol
CAS No. 503-49-1
Meglutol( Meglutol | HMGA | NSC 361411 | NSC-361411 | NSC361411 )
Catalog No. M14708 CAS No. 503-49-1
MEGLUTOL is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 41 | In Stock |
|
100MG | 67 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMeglutol
-
NoteResearch use only, not for human use.
-
Brief DescriptionMEGLUTOL is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids.
-
DescriptionMeglutol is an antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids, and inhibits the activity of hydroxymethylglutarryl CoA reductases, which is the rate limiting enzyme in the biosynthesis of cholesterol.
-
In Vitro——
-
In Vivo——
-
SynonymsMeglutol | HMGA | NSC 361411 | NSC-361411 | NSC361411
-
PathwayMetabolic Enzyme/Protease
-
TargetHMGCR
-
RecptorHMG-CoA reductase
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number503-49-1
-
Formula Weight162.14
-
Molecular FormulaC6H10O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O)CC(C)(O)CC(O)=O
-
Chemical Name3-hydroxy-3-methylpentanedioic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Santarelli F, et al. Ital J Pediatr. 2013 May 24;39:33.
molnova catalog
related products
-
Clinofibrate
Clinofibrate inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR) with IC50 of 0.47 mM.
-
Monacolin J
Monacolin J is a cholesterol biosynthesis inhibitor.
-
Apomine
Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and has been implicated in the regulation of myeloma in vivo. Apomine accelerates the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase and stimulates low-density lipoprotein receptor activity.